{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16839203",
  "DateCompleted": {
    "Year": "2006",
    "Month": "08",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2024",
    "Month": "01",
    "Day": "09"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e69"
    ],
    "Journal": {
      "ISSN": "1553-7374",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "7",
        "PubDate": {
          "Year": "2006",
          "Month": "Jul"
        }
      },
      "Title": "PLoS pathogens",
      "ISOAbbreviation": "PLoS Pathog"
    },
    "ArticleTitle": "Carrageenan is a potent inhibitor of papillomavirus infection.",
    "Pagination": {
      "StartPage": "e69",
      "MedlinePgn": "e69"
    },
    "Abstract": {
      "AbstractText": [
        "Certain sexually transmitted human papillomavirus (HPV) types are causally associated with the development of cervical cancer. Our recent development of high-titer HPV pseudoviruses has made it possible to perform high-throughput in vitro screens to identify HPV infection inhibitors. Comparison of a variety of compounds revealed that carrageenan, a type of sulfated polysaccharide extracted from red algae, is an extremely potent infection inhibitor for a broad range of sexually transmitted HPVs. Although carrageenan can inhibit herpes simplex viruses and some strains of HIV in vitro, genital HPVs are about a thousand-fold more susceptible, with 50% inhibitory doses in the low ng/ml range. Carrageenan acts primarily by preventing the binding of HPV virions to cells. This finding is consistent with the fact that carrageenan resembles heparan sulfate, an HPV cell-attachment factor. However, carrageenan is three orders of magnitude more potent than heparin, a form of cell-free heparan sulfate that has been regarded as a highly effective model HPV inhibitor. Carrageenan can also block HPV infection through a second, postattachment heparan sulfate-independent effect. Carrageenan is in widespread commercial use as a thickener in a variety of cosmetic and food products, ranging from sexual lubricants to infant feeding formulas. Some of these products block HPV infectivity in vitro, even when diluted a million-fold. Clinical trials are needed to determine whether carrageenan-based products are effective as topical microbicides against genital HPVs."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, USA."
          }
        ],
        "LastName": "Buck",
        "ForeName": "Christopher B",
        "Initials": "CB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Thompson",
        "ForeName": "Cynthia D",
        "Initials": "CD"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Roberts",
        "ForeName": "Jeffrey N",
        "Initials": "JN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "M\u00fcller",
        "ForeName": "Martin",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Lowy",
        "ForeName": "Douglas R",
        "Initials": "DR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Schiller",
        "ForeName": "John T",
        "Initials": "JT"
      }
    ],
    "GrantList": [
      {
        "Agency": "Intramural NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Intramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS Pathog",
    "NlmUniqueID": "101238921",
    "ISSNLinking": "1553-7366"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Polysaccharides"
    },
    {
      "RegistryNumber": "9000-07-1",
      "NameOfSubstance": "Carrageenan"
    },
    {
      "RegistryNumber": "9005-49-6",
      "NameOfSubstance": "Heparin"
    },
    {
      "RegistryNumber": "9050-30-0",
      "NameOfSubstance": "Heparitin Sulfate"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Topical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "chemistry",
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CHO Cells"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Capsid"
    },
    {
      "QualifierName": [
        "chemistry",
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Carrageenan"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cricetinae"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Dose-Response Relationship, Drug"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "HeLa Cells"
    },
    {
      "QualifierName": [
        "chemistry",
        "physiology"
      ],
      "DescriptorName": "Heparin"
    },
    {
      "QualifierName": [
        "chemistry",
        "physiology"
      ],
      "DescriptorName": "Heparitin Sulfate"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hydrogen-Ion Concentration"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mice"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "Papillomaviridae"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology",
        "prevention & control"
      ],
      "DescriptorName": "Papillomavirus Infections"
    },
    {
      "QualifierName": [
        "analysis",
        "chemistry"
      ],
      "DescriptorName": "Polysaccharides"
    },
    {
      "QualifierName": [
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Sexually Transmitted Diseases, Viral"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity",
        "physiology"
      ],
      "DescriptorName": "Virion"
    }
  ],
  "CoiStatement": "\n<b>Competing interests.</b> The authors have declared that no competing interests exist."
}